Drug Type Small molecule drug |
Synonyms EGFR-IN-125 |
Target |
Action antagonists |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC30H26N8O |
InChIKeyNKRUHCMBVJSNAB-UHFFFAOYSA-N |
CAS Registry2472802-77-8 |